CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objecti ...
Phase 3
Charlotte, North Carolina, United States and 23 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Charlotte, North Carolina, United States and 176 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...
Phase 3
Charlotte, North Carolina, United States and 50 other locations
Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...
Phase 3
Charlotte, North Carolina, United States and 202 other locations
PK, and PD of SON-DP in participants with relapsed/refractory/intolerant to standard of care therapies, for advanced/ metastatic solid tumors...
Phase 1
Huntersville, North Carolina, United States of America and 4 other locations
survival (PFS) per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 as assessed by the investigator. The hypotheses are that pembro...
Phase 3
Charlotte, North Carolina, United States and 186 other locations
treatments in patients with persistent or recurrent rare epithelial ovarian, fallopian tube, or primary peritoneal tumors. Enrollme...
Phase 2
Charlotte, North Carolina, United States and 53 other locations
Dose (RP2D) in patients with ovarian cancer, and Part C will evaluate combination treatment of INX-315 plus a CDK4/6i and selectiv...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 6 other locations
(with enzalutamide-naïve metastatic castration-resistant prostate cancer) will be randomized to receive either NUV-868 monotherapy, enzaluta...
Phase 1, Phase 2
Huntersville, North Carolina, United States of America and 30 other locations
of CPO-100 administered intravenously in cycles of 3 weekly doses with 1 week rest (1 cycle = 4 weeks) in adult patients with advanced solid tumors...
Phase 1
Huntersville, North Carolina, United States of America and 7 other locations
Clinical trials
Research sites
Resources
Legal